Skip to main content

Spectrophotometry Determination of Factor X with S-2222 in Anticoagulated and Cirrhotic Patients

  • Chapter
Synthetic Substrates in Clinical Blood Coagulation Assays

Part of the book series: Developments in Hematology ((DIHI,volume 1))

Abstract

To have an idea about the usefulness of FX determinations, with S-2222 as a chromogenic substrate, in the control of patients on oral anticoagulants, we have performed a small pilot study in 24 patients who were chronically receiving warfarin and maintained on a Thrombo-test value between 6 and 15%. In a second part of our study we have looked at FX levels in cirrhotic patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aurel I L, Friberger P, Karlsson G, and Claeson G. 1977. A new sensitive and highly specific chromogenic peptide substrate for factor Xa. Thromb.Res. 11, 595–609.

    Article  Google Scholar 

  2. Bachmann F, Duckert F, and Koller F. 1958. The Stuart-Prower factor assay and its clinical significance. Thromb. Diathes. haemorrh. 2, 24–38.

    CAS  Google Scholar 

  3. Egberg N and Bergström K. 1978. Studies on assays for plasma pre- kallikrein and for the monitoring of coumarol therapy. Haemost. 7, 85–91.

    CAS  Google Scholar 

  4. Egberg N and Bergström K. 1979. Synthetic chromogenic substrates in the assay for plasma prekal I ikrein and coagulation factors II and X. In: Chromogenic Peptide Substrates, Chemistry and Clinical Usage. Scully MF and Kakkar VV, eds., Churchill Livingstone, Edinburgh, London and New York, pp 61–68.

    Google Scholar 

  5. Lämmle B, Eichlisberger R, Hänni L, Bounameaux H, Marbet GA, und Duckert F. 1979. Kontrolle der oralen Antikoagulation: Vergleich zwischen Quick- und kolorimetrischer Faktor-X-Bestimmung bei 107 Patienten. Schweiz.Med.Wschr. 109, 1115–1119.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1980 Martinus Nijhoff Publishers bv, The Hague

About this chapter

Cite this chapter

Baele, G. (1980). Spectrophotometry Determination of Factor X with S-2222 in Anticoagulated and Cirrhotic Patients. In: Lijnen, H.R., Collen, D., Verstraete, M. (eds) Synthetic Substrates in Clinical Blood Coagulation Assays. Developments in Hematology, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-8910-8_4

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-8910-8_4

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-009-8912-2

  • Online ISBN: 978-94-009-8910-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics